Advertisement
Here are the top health stories for the day:
NEET-UG 2024: NTA to hold undergraduate medical entrance exam tomorrow
Through an advisory, the National Testing Agency (NTA) has issued important guidelines, instructions to be followed on exam day by the candidates appearing for the National Eligibility cum Entrance Test-Undergraduate (NEET-UG) for 2024.
Tomorrow i.e. Sunday, May 5, 2024, from 02:00 PM to 05:20 PM, NTA is going to conduct NEET-UG 2024 for more than 24 lakh candidates at various centres located in 557 cities across the country including 14 cities outside India.
For more information, click on the link below:
Dabur on ethylene oxide in masala products: ‘Not used in domestic markets’
Dabur India clarified that its domestic masala products, including those under the Badshah brand, are not treated with ethylene oxide. While ethylene oxide is used within prescribed limits for international markets, Dabur ensures adherence to safety standards, as affirmed by the Indian Spice Board. The company's batches for export undergo scrutiny to meet required standards, with a preference for steam sterilization over ethylene oxide.
Despite recent bans on MDH and Everest spices in Singapore and Hong Kong due to elevated ethylene oxide levels, Dabur's masala portfolio remains unaffected. The company emphasized its commitment to safety and established a micro lab to ensure sterilization of export batches without ethylene oxide.
Form expert panel to examine possible side effects, risk factors of Covishield vaccine; seeks plea filed in SC
A plea was submitted to the Supreme Court on Wednesday, urging the establishment of a medical expert panel overseen by a retired apex court judge. This panel would be tasked with assessing potential side effects and risk factors associated with the Covishield vaccine.
It claimed that UK-headquartered pharmaceutical company AstraZeneca has said that its vaccine against COVID-19, which was made under licence in India as Covishield, could cause low platelet counts and formation of blood clots in “very rare” cases.
For more information, click on the link below:
What is FLiRT - The new COVID-19 variant on the rise in the US?
Since the COVID pandemic has slowed down and cases have dropped, there are now new versions of the virus popping up. One of these is called FLiRT, and it's spreading fast in the US. FLiRT comes from a version of the virus called JN.1 that caused a lot of cases last winter. Scientists are especially worried about a part of FLiRT called KP.2.
About 25 percent of the new COVID cases in the US are from KP.2. Experts are still figuring out if FLiRT spreads easily or makes people really sick. They've found that FLiRT has changes in its spike protein, which helps the virus infect people.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.